SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001144204-18-054989
Filing Date
2018-10-23
Accepted
2018-10-23 17:08:31
Documents
5
Period of Report
2018-10-19
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tv505356_8-k.htm 8-K 22091
2 EXHIBIT 10.1 tv505356_ex10-1.htm EX-10.1 58672
3 EXHIBIT 10.2 tv505356_ex10-2.htm EX-10.2 53337
4 EXHIBIT 10.3 tv505356_ex10-3.htm EX-10.3 42835
5 EXHIBIT 99.1 tv505356_ex99-1.htm EX-99.1 17990
  Complete submission text file 0001144204-18-054989.txt   196540
Mailing Address 5 WEST FORSYTH STREET SUITE 200 JACKSONVILLE FL 32202
Business Address 5 WEST FORSYTH STREET SUITE 200 JACKSONVILLE FL 32202 (904) 516-5436
Marker Therapeutics, Inc. (Filer) CIK: 0001094038 (see all company filings)

IRS No.: 880277072 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37939 | Film No.: 181134674
SIC: 2834 Pharmaceutical Preparations